Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1586 of 5804
-
Precision drug tipifarnib targets rare HRAS cancers in kids
Disease control OngoingThis phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have recurred or spread to other places in the body (advanced), lymphoma, or histiocytic disorders, that have a genetic alteration in the gene HRAS. Tipifarnib may bl…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain zaps may boost memory in those at risk for Alzheimer's
Symptom relief OngoingMore than 5 million people live with Alzheimer's dementia (AD) in North America. No effective treatment exists yet probably because by the time AD has developed it is too late to intervene. Mild Cognitive Impairment (MCI) is a clinical state that typically precedes AD. In MCI, th…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for japanese patients with rare bone marrow cancer
Disease control OngoingThe study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This is a Phase 1/2 multicenter, sing…
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Burn surgery infection risk: do antibiotics help or hurt?
Disease control Recruiting nowThe indication of antibiotic prophylaxis in burn patients remains highly controversial and hasn't reached a consensus. The objective of antibiotic prophylaxis would be to reduce the risk of post-operative local and systemic infections. Burn surgery is associated with a high risk …
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug duo aims to halt endometrial cancer growth
Disease control OngoingThis is a phase II single arm trial to determine the percentage of patients without evidence of disease progression on abemaciclib and letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until either unacceptab…
Phase: PHASE2 • Sponsor: Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for myeloma patients with kidney failure: targeted drug tested in dialysis patients
Disease control OngoingBelantamab mafodotin is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb). Renal impairment is a major complication of multiple myeloma (MM) and the majority of MM participants is either at risk or already has r…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pneumonia vaccine shows promise in older adults
⭐️ VACCINE ⭐️ CompletedPrimary Objectives: * Assessed the immune response of the 3 SP0202 formulations, Prevnar 13 and Pneumovax 23 30 days after the administration of the single dose vaccination * Assessed the safety profile of the 3 SP0202 formulations, Prevnar 13 and Pneumovax 23
Phase: PHASE2 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 14:28 UTC
-
New trial could change how doctors help CDH babies at birth
Disease control Recruiting nowIsolated CDH is a rare disease (1/3500) and displays a wide range of severity and outcome. Despite attempts to standardize the management of this disease at birth and during the first months of life, the mortality varies from 20 to 50% according to different hospitals in France a…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Opioid vaccine trial aims to block Drug's brain effects
Disease control Recruiting nowCurrently, abuse of prescription opioid analgesics and heroin is a serious problem in the U.S. Although several medications, including methadone, buprenorphine, and naltrexone, are available and effective in treating opioid use disorder (OUD), long-term relapse rates remain high.…
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to make bone marrow transplants safer
Disease control OngoingThe purpose of this study is to evaluate the safety of reducing and ultimately eliminating anti-thymocyte globulin (ATG) from the haplo-cord transplant conditioning regimen and replacing it with tocilizumab, an IL-6 receptor monoclonal antibody, to improve immune reconstitution a…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Promising drug may shrink rare tumors in kids without surgery
Disease control OngoingThis phase II trial studies the side effects and how well nirogacestat works in treating patients less than 18 years of age with desmoid tumors that has grown after at least one form of treatment by mouth or in the vein that cannot be removed by surgery. Nirogacestat may stop the…
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Medical cannabis vouchers may cut opioid use in chronic pain patients
Disease control CompletedThis study will examine how discounted vouchers for medical cannabis use affects opioid analgesic use in adults with chronic pain. Our study findings will have critically important implications to shape clinical care and medical cannabis policies.
Phase: NA • Sponsor: Vireo Health • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart-Healthy women: exercise and brain games may ward off memory loss
Prevention CompletedOlder women with cardiovascular disease (CVD) are at greater risk for memory loss, an important public health issue due to the negative effects to quality of life and health care costs. This research will be the first to examine the independent and combined effects of a lifestyle…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Could a cancer immunotherapy drug shrink rare sarcomas?
Disease control OngoingThis phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to other places in the body (metastatic). Immunotherapy with monoclonal antib…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Dissolving stent could spare patients a second procedure
Disease control Recruiting nowSignificant experience with biodegradable materials has been reported in the orthopedic literature; in particular; biodegradable stents have been used in the endovascular and urologic epithelium. Stents are typically made from polymeric materials including Polylactic Acid (PLA), …
Sponsor: QualiMed Innovative Medizinprodukte GmbH • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can walking keep cancer away? new study investigates
Prevention OngoingResearchers think that exercise may be able to prevent cancer from coming back by lowering ctDNA levels. The purpose of this study is to explore how aerobic exercise (exercise that stimulates and strengthens the heart and lungs and improves the body's use of oxygen) can reduce th…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
New math models could save lives on liver transplant waitlist
Knowledge-focused CompletedThe MELD score is a predictive model of cirrhosis mortality used in France since 2007 to prioritize access to liver transplantation for patients enrolled in the national waiting list. The predictive value of this score was recently revised downward with a C index of the order of …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Can existing drugs stop COVID-19 from getting worse?
Disease control CompletedThe Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS) study is a two-stage, open-label, randomised controlled trial assessing the efficacy of ruxolitinib (RUX) and fostamatinib (FOS) individually, compared to standard of care in the treatment of COVID-19 pneu…
Phase: PHASE1, PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
HPV Vaccine's Real-World impact under the microscope in sikkim
Prevention Recruiting nowThis project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of…
Sponsor: International Agency for Research on Cancer • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Could a common cholesterol drug help fight a rare liver disease?
Disease control OngoingThis is a randomized, double-blind, placebo controlled multicenter study. A total of 700 patients will be included. After an updated powercalculation 560 was condidered enough The study will include patients with primary sclerosing cholangitis (PSC) for daily intake of 40 mg si…
Phase: PHASE3 • Sponsor: Annika Bergquist • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC